this European Commission reported on Tuesday that it was signed joint purchase agreement with the pharmacist hypra to supply 250 million doses The first Spanish vaccine against the coronavirus responsible for Covid-19. According to European authorities, for now at least 14 member countries He said they will participate in this first purchase and will receive vials of vaccine designed, tested and manufactured in Spain in the coming months.
Purchase agreement with Brussels first to surpass Regarding the hypra vaccine, however, it may not be the last. As Elia Torroella, Director of R&D and Records of the pharmaceutical company, explained in an interview with El Periódico de Catalunya, a newspaper owned by the same group, Prensa Ibérica, a few days ago, this newspaper also included discussions with the company. Countries in Latin America, Southeast Asia and the Middle East middle It will export its vaccine against Covid-19.
Hypra vaccine already administered successfully tested on thousands of volunteerswill be supplied. booster dose inside people over 16 years old already vaccinated against covid-19. Currently, the formula is in the final stages of review by the European Medicines Agency (EMA), which will ultimately decide on its final approval. According to the pharmaceutical company, definitive approval could come just in time for the vaccine campaign to begin this fall.
European vaccine portfolio
Commissioner of Health of the European Commission, Stella KyriakidesHe stated that there are doses of Hipra”add one more option To the comprehensive portfolio of European vaccines”. The joint purchase agreement of vaccines with Hipra actually complements previously signed contracts. AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica, BioNtech-Pfizer, Moderna, Novavax and ValnevaProviding approximately 4,200 million doses to the community market within the framework of the vaccination strategy against Covid-19.
Commissioner of Health of the European Commission, Stella KyriakidesHe stated that there are doses of Hipra”add one more option To the broad portfolio of European vaccines”. “With the rise of covid-19 infections in Europe, we must guarantee maximum preparation As we approach autumn and winter,” Kyriakides said on Tuesday. 81.4% of the European population vaccinated with a complete guide, the aim of Brussels, vaccine coverage with booster dose.